Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Feb 19;109(2):202-210.
doi: 10.1136/archdischild-2023-325871.

2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheterisation: the ARCTIC randomised controlled feasibility trial

Affiliations
Randomized Controlled Trial

2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheterisation: the ARCTIC randomised controlled feasibility trial

Paul Clarke et al. Arch Dis Child Fetal Neonatal Ed. .

Abstract

Objective: Catheter-related sepsis (CRS) is a major complication with significant morbidity and mortality. Evidence is lacking regarding the most appropriate antiseptic for skin disinfection before percutaneous central venous catheter (PCVC) insertion in preterm neonates. To inform the feasibility and design of a definitive randomised controlled trial (RCT) of two antiseptic formulations, we conducted the Antiseptic Randomised Controlled Trial for Insertion of Catheters (ARCTIC) feasibility study to assess catheter colonisation, sepsis, and skin morbidity.

Design: Feasibility RCT.

Setting: Two UK tertiary-level neonatal intensive care units.

Patients: Preterm infants born <34 weeks' gestation scheduled to undergo PCVC insertion.

Interventions: Skin disinfection with either 2% chlorhexidine gluconate (CHG)-aqueous or 2% CHG-70% isopropyl alcohol (IPA) before PCVC insertion and at removal.

Primary outcome: Proportion in the 2% CHG-70% IPA arm with a colonised catheter at removal.

Main feasibility outcomes: Rates of: (1) CRS, catheter-associated sepsis (CAS), and CRS/CAS per 1,000 PCVC days; (2) recruitment and retention; (3) data completeness.

Safety outcomes: Daily skin morbidity scores recorded from catheter insertion until 48 hours post-removal.

Results: 116 babies were randomised. Primary outcome incidence was 4.1% (95% confidence interval: 0.9% to 11.5%). Overall catheter colonisation rate was 5.2% (5/97); CRS 2.3/1000 catheter days; CAS 14.8/1000 catheter days. Recruitment, retention and data completeness were good. No major antiseptic-related skin injury was reported.

Conclusions: A definitive comparative efficacy trial is feasible, but the very low catheter colonisation rate would make a large-scale RCT challenging due to the very large sample size required. ARCTIC provides preliminary reassurance supporting potential safe use of 2% CHG-70% IPA and 2% CHG-aqueous in preterm neonates.

Trial registration number: ISRCTN82571474.

Keywords: Infectious Disease Medicine; Microbiology; Neonatology; Sepsis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Study flow diagram.

References

    1. Ponnusamy V, Venkatesh V, Curley A, et al. . Segmental percutaneous central venous line cultures for diagnosis of catheter-related sepsis. Arch Dis Child Fetal Neonatal Ed 2012;97:F273–8. 10.1136/archdischild-2011-300822 - DOI - PubMed
    1. Ponnusamy V, Perperoglou A, Venkatesh V, et al. . Skin colonisation at the catheter exit site is strongly associated with catheter colonisation and catheter-related sepsis. Acta Paediatr 2014;103:1233–8. 10.1111/apa.12779 - DOI - PubMed
    1. Clarke P, Craig JV, Wain J, et al. . Safety and efficacy of 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheter insertion in preterm neonates: the ARCTIC randomised-controlled feasibility trial protocol. BMJ Open 2019;9:e028022. 10.1136/bmjopen-2018-028022 - DOI - PMC - PubMed
    1. Stoll BJ, Hansen NI, Adams-Chapman I, et al. . Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004;292:2357–65. 10.1001/jama.292.19.2357 - DOI - PubMed
    1. Chau V, Brant R, Poskitt KJ, et al. . Postnatal infection is associated with widespread abnormalities of brain development in premature newborns. Pediatr Res 2012;71:274–9. 10.1038/pr.2011.40 - DOI - PMC - PubMed

Publication types

MeSH terms